Literature DB >> 9440762

Current perspectives on radiation-induced breast cancer.

P E Goss1, S Sierra.   

Abstract

PURPOSE: An approach to screening and detection of radiation-induced breast cancer is offered. Primary and secondary prevention strategies are suggested and the need for prospective clinical trials is emphasized.
METHODS: Data are reviewed from published evidence of radiation-induced breast cancer secondary to atomic bomb radiation, occupational, and therapeutic exposure, especially that incurred during successful treatment of Hodgkin's disease (HD). Preclinical studies are reviewed to explore potential risk factors.
RESULTS: Risk factors evident in the link between radiation and breast cancer include the differentiation of breast tissue as mediated by age and hormonal influence. Evidence is presented exploring the link between genetics and breast cancer, including specific genes such as the BRCA1 and BRCA2 genes, the p53 gene, the ataxia telangiectasia (AT) gene, and other nonspecific alterations in DNA repair proficiency. In light of these findings, steps toward primary prevention are discussed, including avoiding radiation exposure, genetic screening, and manipulation of the hormonal milieu. Secondary prevention may also be possible with the use of tamoxifen, low-fat diets, and/or the consumption of flaxseed.
CONCLUSION: Our current recommendations for patients irradiated before 30 years of age for Hodgkin's disease include breast self-examination (BSE) monthly, yearly mammography 8 years postirradiation, and regular physical examinations every 6 months. Given the clear link between radiation exposure and breast cancer, we strongly recommend a prospective trial randomize patients to different levels of intensity of surveillance to monitor the efficacy of such screening efforts.

Entities:  

Mesh:

Year:  1998        PMID: 9440762     DOI: 10.1200/JCO.1998.16.1.338

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  15 in total

Review 1.  Suitable trial designs and cohorts for preventive breast cancer agents.

Authors:  Kathrin Strasser-Weippl; Paul E Goss
Journal:  Nat Rev Clin Oncol       Date:  2013-10-08       Impact factor: 66.675

2.  [Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma].

Authors:  P Borchmann; K Behringer; A Josting; J U Rueffer; R Schnell; V Diehl; A Engert; H M Kvasnicka; J Thiele
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

3.  Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls.

Authors:  Da-Peng Ding; Ying Zhang; Wen-Li Ma; Xiao-Feng He; Wei Wang; Hai-Lang Yu; Yu-Bo Guo; Wen-Ling Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

4.  A rare complication resulting in a rare disease: radiation-induced male breast cancer.

Authors:  Jamila Alazhri; Constantine Saclarides; Eli Avisar
Journal:  BMJ Case Rep       Date:  2016-04-15

Review 5.  [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

Authors:  Carolin Nestle-Krämling; Edwin Bölke; Wilfried Budach; Matthias Peiper; Dieter Niederacher; Wolfgang Janni; Claus Ferdinand Eisenberger; Wolfram Trudo Knoefel; Axel Scherer; Stephan Ernst Baldus; Guido Lammering; Peter Arne Gerber; Christiane Matuschek
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

6.  Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation.

Authors:  Andrew N J Tutt; Conny Th M van Oostrom; Gillian M Ross; Harry van Steeg; Alan Ashworth
Journal:  EMBO Rep       Date:  2002-02-15       Impact factor: 8.807

7.  A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3.

Authors:  You Zhou; Yingjie Shao; Wenwei Hu; Jinping Zhang; Yufang Shi; Xiangyin Kong; Jingting Jiang
Journal:  Cell Death Differ       Date:  2022-08-17       Impact factor: 12.067

Review 8.  Prevention of breast cancer using SERMs and aromatase inhibitors.

Authors:  Kathrin Strassmer-Weippl; Paul E Goss
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

9.  Breast cancer, dermatofibromas and arsenic.

Authors:  Paul I Dantzig
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Perceptions of breast cancer risk and cancer screening: a qualitative study of young, female Hodgkin's disease survivors.

Authors:  Sharon L Bober; Elyse R Park; Terra Schmookler; Cheryl Medeiros Nancarrow; Lisa Diller
Journal:  J Cancer Educ       Date:  2007       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.